BioSpace News Archive

Biotech Beach

Vical Incorporated Announces Pricing of $25M Underwritten Public Offering of Common Stock

H.C. Wainwright & Co., LLC is acting as the sole book-running manager for the offering.

November 8, 2017

·

2 min read

Arocell AB: Abstract Published Presenting Arocell TK 210 ELISA From the PROMIX Study at the European Society for Medical Oncology Congress in Singapore, November 17-19, 2017

The investigators quantified cell loss using the AroCell TK 210 ELISA kit to measure serum TK1 in serial samples from 145 breast cancer patients undergoing chemotherapy before surgery.

November 8, 2017

·

2 min read

Business

Lundbeck Increased Operating Profit (EBIT) With 126% and EPS by 182% in the First Nine Months of 2017

Revenue reached DKK 12,842 million in the first nine months of 2017 representing an increase of 12% (13% in local currencies) compared to the same period last year.

November 8, 2017

·

2 min read

Business

ThromboGenics Strengthens Leadership Team - Susan Schneider, MD Appointed Chief Medical Officer and Vinciane Vangeersdaele Appointed Chief Commercial Officer

Both will be members of the Company’s executive team reporting to ThromboGenics’ CEO, and they will operate from the Company’s offices in Leuven, Belgium and Iselin, New Jersey, US.

November 8, 2017

·

4 min read

Business

Photocure ASA: Results for the Third Quarter of 2017

Photocure reported total group revenues of NOK 35.6 million in the third quarter of 2017 (35.2).

November 8, 2017

·

4 min read

Business

Protalix BioTherapeutics Reports 2017 Third Quarter Results and Provides Corporate Update

The Company reported a net loss of $32.1 million, or $0.25 per share, basic and diluted, for the nine-month period ended September 30, 2017.

November 8, 2017

·

11 min read

Business

VALNEVA Signs $39.6M IXIARO Supply Contract With U.S. Government

The new agreement will supplement the initial contract Valneva signed with the US military in March 2016 as the maximum quantity of doses allowed in the precedent contract was reached earlier than expected.

November 8, 2017

·

5 min read

Business

Xenon Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Cash and cash equivalents and marketable securities as of September 30, 2017 were $43.8 million, compared to $64.1 million as of December 31, 2016.

November 8, 2017

·

10 min read

Business

ChemoCentryx Reports Third Quarter 2017 Financial Results and Recent Highlights

Pro forma cash, cash equivalents, investments and remaining upfront commitments totaled $154.8 million at September 30, 2017.

November 8, 2017

·

9 min read

Business

Awair Partners With Brown University to Study Effects of Environmental Exposures on Neurodevelopment in Children

Awair today announces its partnership with Brown University’s Baby Imaging Lab to collaborate on a NIH-sponsored project called “Resonance”, a longitudinal study that focuses on understanding how a wide variety of environmental exposures affect child neurodevelopment.

November 8, 2017

·

2 min read